BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53-61. [PMID: 26547628 DOI: 10.1016/j.cytogfr.2015.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Pinheiro D, Dias I, Ribeiro Silva K, Stumbo AC, Thole A, Cortez E, de Carvalho L, Weiskirchen R, Carvalho S. Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview. Cells 2019;8:E1339. [PMID: 31671842 DOI: 10.3390/cells8111339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
2 Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: Implications for fibrosis and cancer. Adv Drug Deliv Rev 2017;121:101-16. [PMID: 28720422 DOI: 10.1016/j.addr.2017.07.010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 17.2] [Reference Citation Analysis]
3 Jiang N, Zhou Y, Zhu M, Zhang J, Cao M, Lei H, Guo M, Gong P, Su G, Zhai X. Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis. Eur J Med Chem 2020;187:111904. [PMID: 31806537 DOI: 10.1016/j.ejmech.2019.111904] [Reference Citation Analysis]
4 Meurer SK, Weiskirchen R. Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition! Front Pharmacol 2018;9:98. [PMID: 29483873 DOI: 10.3389/fphar.2018.00098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Du Y, Yang W, Yang C, Yang X. A comprehensive review on microbiome, aromas and flavors, chemical composition, nutrition and future prospects of Fuzhuan brick tea. Trends in Food Science & Technology 2022;119:452-66. [DOI: 10.1016/j.tifs.2021.12.024] [Reference Citation Analysis]
6 Lee CY, Suk FM, Twu YC, Liao YJ. Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Librosis. Int J Environ Res Public Health 2020;17:E3802. [PMID: 32471116 DOI: 10.3390/ijerph17113802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang YH, Twu YC, Wang CK, Lin FZ, Lee CY, Liao YJ. Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function. Int J Mol Sci 2018;19:E1678. [PMID: 29874879 DOI: 10.3390/ijms19061678] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
8 Schaefer L. Decoding fibrosis: Mechanisms and translational aspects. Matrix Biol 2018;68-69:1-7. [PMID: 29679639 DOI: 10.1016/j.matbio.2018.04.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
9 Kazlauskas A. PDGFs and their receptors. Gene 2017;614:1-7. [PMID: 28267575 DOI: 10.1016/j.gene.2017.03.003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
10 Seo W, Jeong WI. Novel insight into a platelet-derived growth factor-C/Smad3 axis in liver fibrosis. Focus on "Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis". Am J Physiol Cell Physiol 2016;310:C434-5. [PMID: 26791492 DOI: 10.1152/ajpcell.00369.2015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Zhou J, Deng Y, Yan L, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B. Int J Infect Dis 2016;49:94-9. [PMID: 27292607 DOI: 10.1016/j.ijid.2016.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ma WT, Jia YJ, Liu QZ, Yang YQ, Yang JB, Zhao ZB, Yang ZY, Shi QH, Ma HD, Gershwin ME, Lian ZX. Modulation of liver regeneration via myeloid PTEN deficiency. Cell Death Dis 2017;8:e2827. [PMID: 28542148 DOI: 10.1038/cddis.2017.47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
13 Mafanda EK, Kandhi R, Bobbala D, Khan MGM, Nandi M, Menendez A, Ramanathan S, Ilangumaran S. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. Cytokine 2019;124:154501. [DOI: 10.1016/j.cyto.2018.07.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
14 Zeng ZP, Guo JS. Mechanisms and treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2017; 25(7): 569-575 [DOI: 10.11569/wcjd.v25.i7.569] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Wang X, Gao Y, Li Y, Huang Y, Zhu Y, Lv W, Wang R, Gou L, Cheng C, Feng Z, Xie J, Tian J, Yao R. Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells. Cell Death Dis 2020;11:458. [PMID: 32541811 DOI: 10.1038/s41419-020-2575-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Azzam M, El Safy S, Abdelgelil SA, Weiskirchen R, Asimakopoulou A, de Lorenzi F, Lammers T, Mansour S, Tammam S. Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers. Pharmaceutics 2020;12:E590. [PMID: 32630415 DOI: 10.3390/pharmaceutics12060590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Li Z, Chiang YP, He M, Worgall TS, Zhou H, Jiang XC. Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation. iScience 2021;24:103449. [PMID: 34927020 DOI: 10.1016/j.isci.2021.103449] [Reference Citation Analysis]
18 Matsuda M, Seki E. The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix. Food Chem Toxicol 2020;143:111556. [PMID: 32640349 DOI: 10.1016/j.fct.2020.111556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Liu L, Ge W, Zhang Z, Li Y, Xie M, Zhao C, Yao C, Luo C, Wu Z, Wang W, Zhao D, Zhang J, Qiu W, Wang Y. Sublytic C5b-9 triggers glomerular mesangial cell proliferation via enhancing FGF1 and PDGFα gene transcription mediated by GCN5-dependent SOX9 acetylation in rat Thy-1 nephritis. FASEB J 2021;35:e21751. [PMID: 34156114 DOI: 10.1096/fj.202002814RR] [Reference Citation Analysis]
20 Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal Stem Cell Migration and Tissue Repair. Cells. 2019;8. [PMID: 31357692 DOI: 10.3390/cells8080784] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 35.7] [Reference Citation Analysis]
21 Meng F, Khoso MH, Kang K, He Q, Cao Y, Jiang X, Xiao W, Li D. FGF21 ameliorates hepatic fibrosis by multiple mechanisms. Mol Biol Rep 2021;48:7153-63. [PMID: 34536190 DOI: 10.1007/s11033-021-06707-0] [Reference Citation Analysis]
22 Lee C, Li X. Platelet-derived growth factor-C and -D in the cardiovascular system and diseases. Mol Aspects Med 2018;62:12-21. [PMID: 28965749 DOI: 10.1016/j.mam.2017.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
23 Chen Z, Jain A, Liu H, Zhao Z, Cheng K. Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis. J Pharmacol Exp Ther 2019;370:695-702. [PMID: 30886124 DOI: 10.1124/jpet.118.256156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
24 Gu Y, Wang R, Chen P, Li S, Chai X, Chen C, Liu Y, Cao Y, Lv D, Hong Z, Zhu Z, Chai Y, Yuan Y, Chen X. In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.04.010] [Reference Citation Analysis]
25 Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2021;:1-10. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kabra H, Walimbe T, Stuart K, Indey C, Jalgaonkar S, Ikwa E, Skurnac T, Chen J, Woolley A, Snead NM, Bachtell N, Leeming DJ, Karsdal M, Prestwich G, Panitch A, Paderi J. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021;269:120538. [PMID: 33246740 DOI: 10.1016/j.biomaterials.2020.120538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Qian H, Chen L. TRIM proteins in fibrosis. Biomed Pharmacother 2021;144:112340. [PMID: 34678729 DOI: 10.1016/j.biopha.2021.112340] [Reference Citation Analysis]
29 Wu Q, Xu T, Liu Y, Li Y, Yuan J, Yao W, Xu Q, Yan W, Ni C. miR-1224-5p Mediates Mitochondrial Damage to Affect Silica-Induced Pulmonary Fibrosis by Targeting BECN1. Int J Mol Sci 2017;18:E2357. [PMID: 29112159 DOI: 10.3390/ijms18112357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
30 Li L, Zhou J, Li Q, Xu J, Qi J, Bian H. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. Biomed Pharmacother 2018;106:83-91. [PMID: 29957470 DOI: 10.1016/j.biopha.2018.06.102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
32 Duque-Madrid PC, Velasco-Bolaños J, Ceballos-Márquez A, López C, Carmona JU. Intramammary treatment using allogeneic pure platelet-rich plasma in cows with subclinical mastitis caused by Gram-positive bacteria. Sci Rep 2021;11:23737. [PMID: 34887474 DOI: 10.1038/s41598-021-03067-4] [Reference Citation Analysis]
33 Lim BJ, Lee WK, Lee HW, Lee KS, Kim JK, Chang HY, Lee JI. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice. Cell Commun Signal 2018;16:93. [PMID: 30509307 DOI: 10.1186/s12964-018-0306-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
34 Li X, Shao S, Li H, Bi Z, Zhang S, Wei Y, Bai J, Zhang R, Ma X, Ma B, Zhang L, Xie C, Ning W, Zhou H, Yang C. Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. J Cell Mol Med 2020;24:8623-35. [PMID: 32643868 DOI: 10.1111/jcmm.15493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ciceu A, Balta C, Herman H, Gharbia S, Ignat SR, Dinescu S, Váradi J, Fenyvesi F, Gyöngyösi S, Hermenean A, Costache M. Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA. Int J Mol Sci 2021;22:1869. [PMID: 33668543 DOI: 10.3390/ijms22041869] [Reference Citation Analysis]
36 Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SM, Łos MJ, Aghdaei HA, Zali MR, Ghavami S. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol 2020;882:173263. [PMID: 32535098 DOI: 10.1016/j.ejphar.2020.173263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
37 Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies. Int J Mol Sci. 2018;19. [PMID: 30518128 DOI: 10.3390/ijms19123875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
38 Ke Y, Bi X, Yang N, Chu J, Li X, Ma W, Liu H, Wang H, Li L, Li C, Qin Y, Aji T, Shao Y, Lü G, Lin R. Serum platelet-derived growth factor-BB levels as a potential biomarker in assessing the metabolic activity of lesions in alveolar echinococcosis patients. Acta Trop 2022;227:106290. [PMID: 34951977 DOI: 10.1016/j.actatropica.2021.106290] [Reference Citation Analysis]
39 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
40 Schrijver B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, Virakul S, Paridaens D, Peeters RP, van Hagen PM, Dalm VASH, Dik WA. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy. Thyroid 2019;29:395-404. [PMID: 30724135 DOI: 10.1089/thy.2018.0544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
41 Attallah AM, Albannan MS, Omran MM, Zayed R, Saif S, Farid A, Hassany M, Yosry A, Omran D. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br J Biomed Sci 2019;76:105-10. [PMID: 30924403 DOI: 10.1080/09674845.2019.1600325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol 2020;40:151-68. [PMID: 31389060 DOI: 10.1002/jat.3880] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
43 Ghasemi Y, Ghoshoon MB, Taheri M, Negahdaripour M, Nouri F. Cloning, expression and purification of human PDGF-BB gene in Escherichia coli: New approach in PDGF-BB protein production. Gene Reports 2020;19:100653. [DOI: 10.1016/j.genrep.2020.100653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
44 Chen L, Kong D, Xia S, Wang F, Li Z, Zhang F, Zheng S. Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Front Pharmacol 2022;13:891069. [PMID: 35656309 DOI: 10.3389/fphar.2022.891069] [Reference Citation Analysis]
45 Haflidadottir S, Matthews IL, Almaas R. Cytokine profile in children with food allergy following liver transplantation. Pediatr Transplant 2020;24:e13657. [PMID: 32067305 DOI: 10.1111/petr.13657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Sharawy MH, El-Awady MS, Makled MN. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model. J Biochem Mol Toxicol 2021;35:e22745. [PMID: 33749060 DOI: 10.1002/jbt.22745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Mao D, Li Y, Lu C, Liu X, Sheng A, Han K, Zhu X. DNA Nanomachine with Multitentacles for Integral Processing of Nanoparticles and Its Application in Biosensing. ACS Appl Bio Mater 2020;3:2940-7. [DOI: 10.1021/acsabm.9b01219] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol Aspects Med 2019;65:2-15. [PMID: 29958900 DOI: 10.1016/j.mam.2018.06.003] [Cited by in Crossref: 132] [Cited by in F6Publishing: 135] [Article Influence: 33.0] [Reference Citation Analysis]
49 Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res 2018;7:F1000 Faculty Rev-921. [PMID: 30002817 DOI: 10.12688/f1000research.14841.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
50 Li HG, You PT, Xia Y, Cai Y, Tu YJ, Wang MH, Song WC, Quan TM, Ren HY, Liu YW, Dan HX, Xu SQ. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats. Curr Med Sci 2020;40:539-47. [PMID: 32681257 DOI: 10.1007/s11596-020-2211-3] [Reference Citation Analysis]
51 Chen C, Li X, Wang L. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways. Dig Liver Dis 2020;52:324-30. [PMID: 31542221 DOI: 10.1016/j.dld.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Luo H, Zhao F, Zhang F, Liu N. Influence of amygdalin on PDG, IGF and PDGFR expression in HSC-T6 cells. Exp Ther Med 2018;15:3693-8. [PMID: 29556259 DOI: 10.3892/etm.2018.5886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Li Z, Zhu Z, Liu Y, Liu Y, Zhao H. Function and regulation of GPX4 in the development and progression of fibrotic disease. J Cell Physiol 2022. [PMID: 35605092 DOI: 10.1002/jcp.30780] [Reference Citation Analysis]
54 Madarampalli B, Watts GFM, Panipinto PM, Nguygen HN, Brenner MB, Noss EH. Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation. Biochim Biophys Acta Mol Basis Dis 2019;1865:1516-24. [PMID: 30876808 DOI: 10.1016/j.bbadis.2019.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Andrewartha N, Yeoh G. Human Amnion Epithelial Cell Therapy for Chronic Liver Disease. Stem Cells Int 2019;2019:8106482. [PMID: 31485235 DOI: 10.1155/2019/8106482] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
56 Wang S, Yang J, Zhao G, Liu R, Du Y, Cai Z, Luan J, Shen Y, Chen B. Current applications of platelet gels in wound healing-A review. Wound Repair Regen 2021;29:370-9. [PMID: 33749992 DOI: 10.1111/wrr.12896] [Reference Citation Analysis]
57 Yamada M, Hirai Y, Inoue D, Komatsu S, Uchida T, Kojima T, Tomiyasu T, Yoshikawa N, Oda T. Increased expression of epimorphin in a peritoneal fibrosis mouse model. Perit Dial Int 2021;:8968608211051572. [PMID: 34641723 DOI: 10.1177/08968608211051572] [Reference Citation Analysis]
58 Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y, Yao Y, Ye T. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front Cell Dev Biol 2021;9:730176. [PMID: 34621747 DOI: 10.3389/fcell.2021.730176] [Reference Citation Analysis]
59 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
60 Li Z, Ding Q, Ling LP, Wu Y, Meng DX, Li X, Zhang CQ. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase. World J Gastroenterol 2018; 24(7): 819-832 [PMID: 29467552 DOI: 10.3748/wjg.v24.i7.819] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
61 Chen H, Gan Q, Yang C, Peng X, Qin J, Qiu S, Jiang Y, Tu S, He Y, Li S, Yang H, Tao L, Peng Y. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis. J Transl Med 2019;17:280. [PMID: 31443720 DOI: 10.1186/s12967-019-2027-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Chen H, Chen X, Wang G. Platelets: A review of their function and effects in liver diseases. Liver Research 2020;4:129-35. [DOI: 10.1016/j.livres.2020.08.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Piccolo P, Ferriero R, Barbato A, Attanasio S, Monti M, Perna C, Borel F, Annunziata P, Carissimo A, De Cegli R, Quagliata L, Terracciano LM, Housset C, Teckman JH, Mueller C, Brunetti-Pierri N. Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis. Proc Natl Acad Sci U S A 2021;118:e2025242118. [PMID: 33649241 DOI: 10.1073/pnas.2025242118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gulcicek OB, Solmaz A, Yiğitbaş H, Ercetin C, Yavuz E, Ozdogan K, Arici S, Akkalp AK, Sarac T, Çelebi F, Celik A. Comparison of the Effects of Glutamine, Curcumin, and Nesfatin-1 on the Gastric Serosal Surface Neomucosa Formation: An Experimental Rodent Model. Gastroenterol Res Pract 2016;2016:2081962. [PMID: 27525002 DOI: 10.1155/2016/2081962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Lee C, Kim M, Han J, Yoon M, Jung Y. Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis. Biomedicines 2021;9:1598. [PMID: 34829827 DOI: 10.3390/biomedicines9111598] [Reference Citation Analysis]
66 Yin X, Lin X, Ren X, Yu B, Liu L, Ye Z, Chen Q, Lee C, Lu W, Yu D, Li X. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets. Pharmacol Res 2019;146:104277. [PMID: 31112749 DOI: 10.1016/j.phrs.2019.104277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
67 Laskaratos F, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: An unsolved mystery? Cancer 2017;123:4770-90. [DOI: 10.1002/cncr.31079] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
68 Yu J, Hu Y, Gao Y, Li Q, Zeng Z, Li Y, Chen H. Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis. Cell Death Discov 2018;4:34. [PMID: 30245857 DOI: 10.1038/s41420-018-0095-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
69 Eulenberg VM, Lidbury JA. Hepatic Fibrosis in Dogs. J Vet Intern Med. 2018;32:26-41. [PMID: 29194760 DOI: 10.1111/jvim.14891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
70 Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
71 Du Z, Lin Z, Wang Z, Liu D, Tian D, Xia L. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway. Lab Invest 2020;100:1042-56. [DOI: 10.1038/s41374-020-0425-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
72 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Li Y, Ren HT. Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study. J Zhejiang Univ Sci B 2017;18:994-1001. [PMID: 29119737 DOI: 10.1631/jzus.B1700052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
75 Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular Mechanisms of Liver Fibrosis. Front Pharmacol 2021;12:671640. [PMID: 34025430 DOI: 10.3389/fphar.2021.671640] [Reference Citation Analysis]
76 Li F, Ma Z, Liu H, Zhang Q, Cai X, Qu Y, Xu M, Lu L. Y-box Protein-1 Regulates the Expression of Collagen I in Hepatic Progenitor Cells via PDGFR-β/ERK/p90RSK Signalling. Stem Cells Int 2017;2017:6193106. [PMID: 28928774 DOI: 10.1155/2017/6193106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
77 Saraswati S, Lietman CD, Li B, Mathew S, Zent R, Young PP. Small proline-rich repeat 3 is a novel coordinator of PDGFRβ and integrin β1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts. FASEB J 2020;34:7885-904. [PMID: 32297675 DOI: 10.1096/fj.201902815R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]